UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) was down 8.2% during trading on Wednesday. The stock traded as low as $358.32 and last traded at $357.6790. 5,018,678 shares traded hands during trading, a decline of 30% from the average daily volume of 7,150,820 shares. The stock had previously closed at $389.68.
Key Stories Impacting UnitedHealth Group
Investors following UNH have been watching these stories:
- Positive Sentiment: UnitedHealth raised its 2026 adjusted earnings guidance for the third time this year, to at least $20.50 per share. Higher premiums, benefit reductions and exits from less-profitable markets have helped improve the health insurance operating margin. Article: UnitedHealth Keeps Raising Guidance
- Positive Sentiment: Management is targeting 13% to 16% long-term earnings growth. Optum’s scale—including services for more than 120 million patients and consumers—offers growth opportunities beyond the insurance business. Article: UnitedHealth’s Long-Term Earnings Growth Target
- Neutral Sentiment: A Zacks industry outlook identified UnitedHealth among health-plan companies positioned to benefit from membership trends and healthcare technology, though the coverage is sector-wide rather than company-specific. Article: Zacks Industry Outlook
Analyst Ratings Changes
UNH has been the subject of several recent research reports. Sanford C. Bernstein reduced their target price on shares of UnitedHealth Group from $512.00 to $500.00 and set an "outperform" rating for the company in a report on Wednesday, October 14th. DA Davidson set a $512.00 price target on shares of UnitedHealth Group in a report on Tuesday, July 21st. Stephens set a $500.00 price objective on UnitedHealth Group in a research note on Friday, October 16th. Erste Group Bank cut UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Thursday, August 27th. Finally, Robert W. Baird lowered their target price on UnitedHealth Group from $453.00 to $427.00 and set a "neutral" rating on the stock in a research note on Wednesday, October 14th. Twenty research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $463.93.
View Our Latest Stock Report on UNH
UnitedHealth Group Price Performance
The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66. The stock has a 50-day moving average price of $391.42 and a 200 day moving average price of $366.73. The stock has a market capitalization of $318.02 billion, a price-to-earnings ratio of 20.29, a PEG ratio of 1.49 and a beta of 0.51.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, topping analysts' consensus estimates of $4.14 by $0.55. The company had revenue of $112.72 billion during the quarter, compared to analysts' expectations of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. UnitedHealth Group's quarterly revenue was down .4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend is Monday, December 7th. UnitedHealth Group's dividend payout ratio is presently 53.00%.
Insider Activity
In other news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. This trade represents a 7.09% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.19% of the stock is owned by company insiders.
Hedge Funds Weigh In On UnitedHealth Group
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Wellington Altus USA Inc. lifted its stake in UnitedHealth Group by 97.1% in the 2nd quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate's stock valued at $28,000 after buying an additional 33 shares in the last quarter. Security National Bank of SO Dak purchased a new stake in UnitedHealth Group during the 2nd quarter worth approximately $29,000. Nvwm LLC raised its holdings in shares of UnitedHealth Group by 89.2% during the third quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate's stock valued at $26,000 after acquiring an additional 33 shares during the last quarter. Aberdeen Wealth Management LLC acquired a new position in shares of UnitedHealth Group during the second quarter valued at approximately $31,000. Finally, Compass Wealth Management LLC purchased a new position in shares of UnitedHealth Group in the third quarter valued at approximately $29,000. 87.86% of the stock is owned by hedge funds and other institutional investors.
About UnitedHealth Group
(
Get Free Report)
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.